BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19245264)

  • 1. Epiquinamide: a poison that wasn't from a frog that was.
    Fitch RW; Sturgeon GD; Patel SR; Spande TF; Garraffo HM; Daly JW; Blaauw RH
    J Nat Prod; 2009 Feb; 72(2):243-7. PubMed ID: 19245264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioassay-guided isolation of epiquinamide, a novel quinolizidine alkaloid and nicotinic agonist from an Ecuadoran poison frog, Epipedobates tricolor.
    Fitch RW; Garraffo HM; Spande TF; Yeh HJ; Daly JW
    J Nat Prod; 2003 Oct; 66(10):1345-50. PubMed ID: 14575435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short access to (+)-lupinine and (+)-epiquinamide via double hydroformylation.
    Airiau E; Spangenberg T; Girard N; Breit B; Mann A
    Org Lett; 2010 Feb; 12(3):528-31. PubMed ID: 20038131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.
    Fitch RW; Spande TF; Garraffo HM; Yeh HJ; Daly JW
    J Nat Prod; 2010 Mar; 73(3):331-7. PubMed ID: 20337496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
    Fitch RW; Snider BB; Zhou Q; Foxman BM; Pandya AA; Yakel JL; Olson TT; Al-Muhtasib N; Xiao Y; Welch KD; Panter KE
    J Nat Prod; 2018 Apr; 81(4):1029-1035. PubMed ID: 29671588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of (+)-epiquinamide.
    Wijdeven MA; Botman PN; Wijtmans R; Schoemaker HE; Rutjes FP; Blaauw RH
    Org Lett; 2005 Sep; 7(18):4005-7. PubMed ID: 16119953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic instinct: design, synthesis and evaluation of (+)-sparteine surrogates for asymmetric synthesis.
    O'Brien P
    Chem Commun (Camb); 2008 Feb; (6):655-67. PubMed ID: 18478687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A versatile approach for the asymmetric syntheses of (1R,9aR)-epiquinamide and (1R,9aR)-homopumiliotoxin 223G.
    Huang PQ; Guo ZQ; Ruan YP
    Org Lett; 2006 Mar; 8(7):1435-8. PubMed ID: 16562910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytisine: a natural product lead for the development of drugs acting at nicotinic acetylcholine receptors.
    Pérez EG; Méndez-Gálvez C; Cassels BK
    Nat Prod Rep; 2012 May; 29(5):555-67. PubMed ID: 22367109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epibatidine is a nicotinic analgesic.
    Qian C; Li T; Shen TY; Libertine-Garahan L; Eckman J; Biftu T; Ip S
    Eur J Pharmacol; 1993 Dec; 250(3):R13-4. PubMed ID: 8112391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric synthesis of (-)-1-hydroxyquinolizidinone, a common intermediate for the syntheses of (-)-homopumiliotoxin 223G and (-)-epiquinamide.
    Voituriez A; Ferreira F; Pérez-Luna A; Chemla F
    Org Lett; 2007 Nov; 9(23):4705-8. PubMed ID: 17929934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of poison-frog alkaloids 233A, 235U, and 251AA and their inhibitory effects on neuronal nicotinic acetylcholine receptors.
    Toyooka N; Kobayashi S; Zhou D; Tsuneki H; Wada T; Sakai H; Nemoto H; Sasaoka T; Garraffo HM; Spande TF; Daly JW
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5872-5. PubMed ID: 17827002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Cytisine and derivatives: synthesis, reactivity, and applications.
    Rouden J; Lasne MC; Blanchet J; Baudoux J
    Chem Rev; 2014 Jan; 114(1):712-78. PubMed ID: 24117010
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass spectrometry of bis-quinolizidine alkaloids: 2- and 17-alkyl-substituted derivatives of sparteine and lupanine.
    Wyrzykiewicz E; Boczoń W; Koziol B
    J Mass Spectrom; 2000 Nov; 35(11):1271-7. PubMed ID: 11114084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolizidine and quinolizidine alkaloids.
    Michael JP
    Nat Prod Rep; 2001 Oct; 18(5):520-42. PubMed ID: 11699884
    [No Abstract]   [Full Text] [Related]  

  • 16. Histrionicotoxin alkaloids finally detected in an ant.
    Jones TH; Adams RM; Spande TF; Garraffo HM; Kaneko T; Schultz TR
    J Nat Prod; 2012 Nov; 75(11):1930-6. PubMed ID: 23088730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.
    Rozengart EV
    Dokl Biochem Biophys; 2003; 388():39-42. PubMed ID: 12741131
    [No Abstract]   [Full Text] [Related]  

  • 18. A readily-accessible (+)-sparteine surrogate.
    Dearden MJ; Firkin CR; Hermet JP; O'Brien P
    J Am Chem Soc; 2002 Oct; 124(40):11870-1. PubMed ID: 12358529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of (+)-sparteine-like diamines for asymmetric synthesis.
    Dearden MJ; McGrath MJ; O'Brien P
    J Org Chem; 2004 Aug; 69(17):5789-92. PubMed ID: 15307761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.